| Company Name: |
Jinan Kabotang Biological Technology Co.,Ltd. Gold
|
| Tel: |
0531-61320525 15866703830 |
| Email: |
figo.gao@foxmail.com |
| Products Intro: |
Product Name:5-O-TERT-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-LYXONO-1,4-LACTONE
CAS:130222-84-3
Purity:98% HPLC Package:1kg
|
5-O-TERT-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-LYXONO-1,4-LACTONE manufacturers
|
| | 5-O-TERT-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-LYXONO-1,4-LACTONE Basic information |
| Product Name: | 5-O-TERT-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-LYXONO-1,4-LACTONE | | Synonyms: | 5-O-TERT-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-LYXONO-1,4-LACTONE;(3AR,6R,6AR)-6-(((TERT-BUTYLDIPHENYLSILYL)OXY)METHYL)-2,2-DIMETHYLDIHYDROFURO[3,4-D][1,3]DIOXOL-4(3AH)-ONE;D-Ribonic acid, 5-O-[(1,1-dimethylethyl)diphenylsilyl]-2,3-O-(1-methylethylidene)-, γ-lactone;5-O-t-Butyldiphenyl silyl-2,3-O-isopropylidene-D-ribono-1,4-lactone;5-(tert-butyldiphenylsilyl)-2,3-O-isopropylidene-D-ribono-1,4-lactone;2-O,3-O-isopropylidene-5-O-(tert-Butyldiphenylsilyl)-D-Ribonic Acid-1,4-Lactone;5-O-(tert-Butyldiphenylsilyl)-2,3-isopropylidene-D-ribonolactone;D-Ribonicacid,5-O-[(1,1-dimethylethyl)diphenylsilyl]-2,3-O-(1-methylethylidene)-,γ-lactone | | CAS: | 130222-84-3 | | MF: | C24H30O5Si | | MW: | 426.5775 | | EINECS: | | | Product Categories: | | | Mol File: | 130222-84-3.mol |  |
| | 5-O-TERT-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-LYXONO-1,4-LACTONE Chemical Properties |
| Melting point | 96-97 °C | | Boiling point | 495.4±45.0 °C(Predicted) | | density | 1.16±0.1 g/cm3(Predicted) |
| | 5-O-TERT-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-LYXONO-1,4-LACTONE Usage And Synthesis |
| Uses | 5-O-(tert-Butyldiphenylsilyl)-2,3-isopropylidene-D-ribonolactone is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 5-O-TERT-BUTYLDIPHENYLSILYL-2,3-O-ISOPROPYLIDENE-D-LYXONO-1,4-LACTONE Preparation Products And Raw materials |
|